Conclusion 1. EGFR gene amplification and rearrangement rarely occur in human malignant hematologic disorders.
结论EGFR基因的扩增与重排较少发生在人类血液系统恶性疾患中。
Hematopoietic stem cell transplantation (HSCT) is performed for complete healing of hematologic disorders and as a supportive therapy after high-dose chemotherapy against malignant diseases.
造血干细胞移植(HSCT)常被用来治疗血液系统疾病和作为血液系统恶性疾病高剂量化疗后的支持治疗。
Hematopoietic stem cell transplantation (HSCT) is performed for complete healing of hematologic disorders and as a supportive therapy after high-dose chemotherapy against malignant diseases.
造血干细胞移植(HSCT)常被用来治疗血液系统疾病和作为血液系统恶性疾病高剂量化疗后的支持治疗。
应用推荐